Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Global Infusion Pump Market size was valued at USD 18.01 Billion in 2024 and is poised to grow from USD 19.49 Billion in 2025 to USD 36.61 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026–2033).

    The global infusion pump market outlook is highly competitive, with key players including Baxter International, B. Braun Melsungen, ICU Medical, Medtronic, and Fresenius Kabi. Companies focus on strategic mergers, technological innovation, and regulatory approvals to expand market presence. For example, Baxter emphasizes AI-integrated smart pumps, while B. Braun invests in wireless connectivity. ICU Medical’s acquisition of Smiths Medical strengthened its infusion portfolio, enhancing its global distribution and product diversity. 'Baxter International Inc. (USA)', 'B. Braun Melsungen AG (Germany)', 'ICU Medical, Inc. (USA)', 'Medtronic plc (Ireland)', 'Fresenius Kabi AG (Germany)', 'Smiths Medical (United Kingdom)', 'Terumo Corporation (Japan)', 'Nipro Corporation (Japan)', 'Moog Inc. (USA)', 'Avanos Medical, Inc. (USA)', 'Zyno Medical LLC (USA)', 'Micrel Medical Devices SA (Greece)', 'vTitan Corporation (India)', 'Roche Diagnostics (Switzerland)', 'Mindray Medical International Limited (China)'

    The global shift toward home-based care, driven by rising healthcare costs and patient preference for comfort and convenience, is boosting demand for portable and user-friendly infusion pumps. These devices enable chronic disease management outside hospital settings, supporting trends in outpatient care, telemedicine, and remote patient monitoring.

    Shift Toward Home-Based and Ambulatory Infusion Care: Increasing demand for home healthcare and outpatient treatment is driving adoption of portable, battery-operated infusion pumps. Patients with chronic illnesses prefer convenient, cost-effective therapy outside hospitals. This global infusion pump market trend is boosting innovation in compact, wearable devices with remote monitoring, supporting the global shift toward decentralized, patient-centric care delivery models.

    How does Advanced Healthcare Infrastructure Support Infusion Pump Growth?

    Feedback From Our Clients

    Global Infusion Pump Market

    Report ID: SQMIG35A2184

    $5,300
    BUY NOW